Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 60

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines

Yao, Yongxiu, Zhao, Yuguang, Smith, Lorraine P., Lawrie, Charles H., Saunders, Nigel J., Watson, Michael, Nair, Venugopal · 2009 · Journal of General Virology

Abstract

MicroRNAs (miRNAs) are increasingly recognized to play crucial roles in regulation of gene expression in different biological events, including many sporadic forms of cancer. However, despite the involvement of several viruses in inducing cancer, only a limited number of studies have been carried out to examine the miRNA expression signatures in virus-induced neoplasia, particularly in herpesvirus-induced tumours where virus-encoded miRNAs also contribute significantly to the miRNome of the tumour cell. Marek's disease (MD) is a naturally occurring, rapid-onset CD4+T-cell lymphoma of poultry, induced by the highly contagious Marek's disease virus (MDV). High levels of expression of virus-encoded miRNAs and altered expression of several host-encoded miRNAs were demonstrated in the MDV-transformed lymphoblastoid cell line MSB-1. In order to identify the miRNA expression signature specific to MDV-transformed cells, we examined the global miRNA expression profiles in seven distinct MDV-transformed cell lines by microarray analysis. This study revealed that, in addition to the high levels of MDV-encoded miRNAs, these MD tumour-derived lymphoblastoid cell lines showed altered expression of several host-encoded miRNAs. Comparison of the miRNA expression profiles of these cell lines with the MDV-negative, retrovirus-transformed AVOL-1 cell line showed that miR-150 and miR-223 are downregulated irrespective of the viral aetiology, whereas downregulation of miR-155 was specific for MDV-transformed tumour cells. Thus, increased expression of MDV-encoded miRNAs with specific downregulation of miR-155 can be considered as unique expression signatures for MD tumour cells. Analysis of the functional targets of these miRNAs would contribute to the understanding of the molecular pathways of MD oncogenicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1099/vir.0.009902-0

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 51

  1. Akiyama, 1974, Two cell lines from lymphomas of Marek's disease, Biken J, 17, 105
  2. Baek, 2008, The impact of microRNAs on protein output, Nature, 455, 64, 10.1038/nature07242 · DOI · Paper page
  3. Bornkamm, 2005, Stringent doxycycline-dependent control of gene activities using an episomal one-vector system, Nucleic Acids Res, 33, e137, 10.1093/nar/gni137 · DOI
  4. Burnside, 2007, Genomics and Marek's disease virus, Cytogenet Genome Res, 117, 376, 10.1159/000103201 · DOI
  5. Burnside, 2006, Marek's disease virus encodes microRNAs that map to meq and the latency-associated transcript, J Virol, 80, 8778, 10.1128/JVI.00831-06 · DOI · Paper page
  6. Burnside, 2008, Deep sequencing of chicken microRNAs, BMC Genomics, 9, 185, 10.1186/1471-2164-9-185 · DOI
  7. Cai, 2005, Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells, Proc Natl Acad Sci U S A, 102, 5570, 10.1073/pnas.0408192102 · DOI · Paper page
  8. Calin, 2006, MicroRNA signatures in human cancers, Nat Rev Cancer, 6, 857, 10.1038/nrc1997 · DOI · Paper page
  9. Calin, 2007, Investigation of microRNA alterations in leukemias and lymphomas, Methods Enzymol, 427, 193
  10. Calnek, 1986, Marek's disease: a model for herpesvirus oncology, Crit Rev Microbiol, 12, 293, 10.3109/10408418509104432 · DOI
  11. Chan, 1988, Identification of the avian homologues of mammalian CD4 and CD8 antigens, J Immunol, 140, 2133, 10.4049/jimmunol.140.7.2133 · DOI · Paper page
  12. Cosmopoulos, 2008, Comprehensive profiling of EBV microRNAs in nasopharyngeal carcinoma, J Virol, 83, 2357, 10.1128/JVI.02104-08 · DOI · Paper page
  13. Cullen, 2006, Viruses and microRNAs, Nat Genet, 38, S25, 10.1038/ng1793 · DOI · Paper page
  14. Cullen, 2009, Viral and cellular messenger RNA targets of viral microRNAs, Nature, 457, 421, 10.1038/nature07757 · DOI · Paper page
  15. Fabbri, 2008, MicroRNAs and noncoding RNAs in hematological malignancies: molecular, clinical and therapeutic implications, Leukemia, 22, 1095, 10.1038/leu.2008.30 · DOI
  16. Garcia, 2008, Hematopoietic lineage commitment: miRNAs add specificity to a widely expressed transcription factor, Dev Cell, 14, 815, 10.1016/j.devcel.2008.05.011 · DOI
  17. Garzon, 2008, MicroRNAs in normal and malignant hematopoiesis, Curr Opin Hematol, 15, 352, 10.1097/MOH.0b013e328303e15d · DOI · Paper page
  18. Ghosh, 2008, Cellular versus viral microRNAs in host–virus interaction, Nucleic Acids Res, 37, 1035, 10.1093/nar/gkn1004 · DOI · Paper page
  19. Gottwein, 2008, Viral and cellular microRNAs as determinants of viral pathogenesis and immunity, Cell Host Microbe, 3, 375, 10.1016/j.chom.2008.05.002 · DOI · Paper page
  20. Griffiths-Jones, 2008, miRBase: tools for microRNA genomics, Nucleic Acids Res, 36, D154, 10.1093/nar/gkm952 · DOI · Paper page
  21. Javier, 2008, The history of tumor virology, Cancer Res, 68, 7693, 10.1158/0008-5472.CAN-08-3301 · DOI · Paper page
  22. Johnnidis, 2008, Regulation of progenitor cell proliferation and granulocyte function by microRNA-223, Nature, 451, 1125, 10.1038/nature06607 · DOI · Paper page
  23. Lambeth, 2009, MicroRNAs 221 and 222 target p27Kip1 in Marek's disease virus-transformed tumour cell line MSB-1, J Gen Virol, 90, 1164, 10.1099/vir.0.007831-0 · doi:10.1099/vir.0.007831-0
  24. Lawrie, 2007, MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma, Int J Cancer, 121, 1156, 10.1002/ijc.22800 · DOI · Paper page
  25. Lawrie, 2008, MicroRNA expression in lymphocyte development and malignancy, Leukemia, 22, 1440, 10.1038/sj.leu.2405083 · DOI
  26. Lee, 2009, MicroRNAs in cancer, Annu Rev Pathol, 4, 199, 10.1146/annurev.pathol.4.110807.092222 · DOI · Paper page
  27. Lin, 2008, c-Myb is an evolutionary conserved miR-150 target and miR-150/c-Myb interaction is important for embryonic development, Mol Biol Evol, 25, 2189, 10.1093/molbev/msn165 · DOI
  28. Lowery, 2008, MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management, Clin Cancer Res, 14, 360, 10.1158/1078-0432.CCR-07-0992 · DOI
  29. Lu, 2008, MicroRNA-mediated control of cell fate in megakaryocyte–erythrocyte progenitors, Dev Cell, 14, 843, 10.1016/j.devcel.2008.03.012 · DOI · Paper page
  30. Martinez, 2008, Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells, Oncogene, 27, 2575, 10.1038/sj.onc.1210919 · DOI · Paper page
  31. Morgan, 2008, Sequence conservation and differential expression of Marek's disease virus microRNAs, J Virol, 82, 12213, 10.1128/JVI.01722-08 · DOI
  32. Nazerian, 1987, An updated list of avian cell lines and transplantable tumours, Avian Pathol, 16, 527, 10.1080/03079458708436402 · doi:10.1080/03079458708436402
  33. Ozen, 2008, Widespread deregulation of microRNA expression in human prostate cancer, Oncogene, 27, 1788, 10.1038/sj.onc.1210809 · DOI · Paper page
  34. Petherbridge, 2004, Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes, J Virol, 78, 13376, 10.1128/JVI.78.23.13376-13380.2004 · DOI
  35. Pfeffer, 2004, Identification of virus-encoded microRNAs, Science, 304, 734, 10.1126/science.1096781 · DOI · Paper page
  36. Pfeffer, 2005, Identification of microRNAs of the herpesvirus family, Nat Methods, 2, 269, 10.1038/nmeth746 · DOI · Paper page
  37. Pratt, 2009, The microRNAs of Epstein–Barr virus are expressed at dramatically differing levels among cell lines, Virology, 386, 387, 10.1016/j.virol.2009.01.006 · DOI
  38. Rosenfeld, 2008, MicroRNAs accurately identify cancer tissue origin, Nat Biotechnol, 26, 462, 10.1038/nbt1392 · DOI · Paper page
  39. Ruike, 2008, Global correlation analysis for micro-RNA and mRNA expression profiles in human cell lines, J Hum Genet, 53, 515, 10.1007/s10038-008-0279-x · DOI
  40. Schotte, 2008, Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia, Leukemia, 23, 313, 10.1038/leu.2008.286 · DOI · Paper page
  41. Shaner, 2004, Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein, Nat Biotechnol, 22, 1567, 10.1038/nbt1037 · DOI · Paper page
  42. Skalsky, 2007, Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155, J Virol, 81, 12836, 10.1128/JVI.01804-07 · DOI · Paper page
  43. Sullivan, 2007, Identification of viral microRNAs, Methods Enzymol, 427, 3
  44. Wiemer, 2007, The role of microRNAs in cancer: no small matter, Eur J Cancer, 43, 1529, 10.1016/j.ejca.2007.04.002 · DOI · Paper page
  45. Xiao, 2007, MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb, Cell, 131, 146, 10.1016/j.cell.2007.07.021 · DOI · Paper page
  46. Xu, 2008, Analysis of the expression profiles of Marek's disease virus-encoded microRNAs by real-time quantitative PCR, J Virol Methods, 149, 201, 10.1016/j.jviromet.2008.02.005 · DOI
  47. Yao, 2007, Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence conservation with those encoded by MDV-1, J Virol, 81, 7164, 10.1128/JVI.00112-07 · DOI
  48. Yao, 2008, MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs, J Virol, 82, 4007, 10.1128/JVI.02659-07 · DOI
  49. Yeung, 2008, Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1, Cancer Res, 68, 8976, 10.1158/0008-5472.CAN-08-0769 · DOI · Paper page
  50. Zhao, 2009, A functional MicroRNA-155 ortholog encoded by the oncogenic Marek's disease virus, J Virol, 83, 489, 10.1128/JVI.01166-08 · DOI
  51. Zhou, 2007, miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely, Proc Natl Acad Sci U S A, 104, 7080, 10.1073/pnas.0702409104 · DOI · Paper page

Cited by

See all 60

Metadata

Authors
Yao, Y., Zhao, Y., Smith, L. P., Lawrie, C. H., Saunders, N. J., Watson, M., & Nair, V.
Affiliations
  • Division of Microbiology, Institute for Animal Health, Compton RG20 7NN, UK
  • LRF Molecular Haematology Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford OX3 9DU, UK
  • Bacterial Pathogenesis and Functional Genomics Group, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK
Venue
Journal of General Virology
Published
2009-07-01
Volume
90
Issue
7
Pages
1551-1559
ISSN
  • 0022-1317
  • 1465-2099
Cited by
60
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. https://app.cochat.ai/papers/10.1099/vir.0.009902-0
The paper
Yao, Y., Zhao, Y., Smith, L. P., Lawrie, C. H., Saunders, N. J., Watson, M., & Nair, V. (2009). Differential expression of microRNAs in Marek's disease virus-transformed T-lymphoma cell lines. Journal of General Virology. https://doi.org/10.1099/vir.0.009902-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.